3.0.0 2374 2023-01-11T13:44:08Z 2023-01-11T13:44:08Z House HR 2019-04-29 116 [Congressional Record Volume 165, Number 69 (Monday, April 29, 2019)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. JEFFRIES:H.R. 2374.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 18, to make all laws, whichshall be necessary and proper for carrying into execution theforegoing powers.[Page H3303]]]> hsju00 Judiciary Committee House Standing Reported by 2020-12-24T15:28:52Z Markup by 2019-04-30T21:00:03Z Referred to 2019-04-29T18:00:07Z H. Rept. 116-694 Stop STALLING Act 116 1224 S 2019-06-28 Placed on Senate Legislative Calendar under General Orders. Calendar No. 130. Related bill CRS Related bill House Lowering Prescription Drug Prices for America’s Seniors and Families Act of 2020 116 3384 S 2020-03-03 Read twice and referred to the Committee on Finance. Related bill CRS 2020-12-24 Placed on the Union Calendar, Calendar No. 577. Calendars H12410 2 House floor actions U00577 2020-12-24 Reported by the Committee on Judiciary. H. Rept. 116-694. Committee H12200 2 House floor actions hsju00 Judiciary Committee 2020-12-24 Reported by the Committee on Judiciary. H. Rept. 116-694. Committee 5000 9 Library of Congress hsju00 Judiciary Committee 2019-04-30 hsju00 Judiciary Committee 1 House committee actions Ordered to be Reported by Voice Vote. Committee 2019-04-30 hsju00 Judiciary Committee 1 House committee actions Committee Consideration and Mark-up Session Held. Committee 2019-04-29 Referred to the House Committee on the Judiciary. IntroReferral H11100 2 House floor actions hsju00 Judiciary Committee 2019-04-29 Introduced in House IntroReferral Intro-H 9 Library of Congress 2019-04-29 Introduced in House IntroReferral 1000 9 Library of Congress J000294 Rep. Jeffries, Hakeem S. [D-NY-8] Hakeem Jeffries D NY S. 8 N S000244 Rep. Sensenbrenner, F. James, Jr. [R-WI-5] F. SENSENBRENNER R WI JAMES 5 2019-04-29 True N000002 Rep. Nadler, Jerrold [D-NY-10] JERROLD NADLER D NY 10 2019-04-29 True C001093 Rep. Collins, Doug [R-GA-9] Doug Collins R GA 9 2019-04-29 True C001084 Rep. Cicilline, David N. [D-RI-1] David Cicilline D RI N. 1 2019-04-29 True W000800 Rep. Welch, Peter [D-VT-At Large] Peter Welch D VT 0 2019-04-29 True C001068 Rep. Cohen, Steve [D-TN-9] Steve Cohen D TN 9 2019-04-30 False P000599 Rep. Posey, Bill [R-FL-8] Bill Posey R FL 8 2019-12-09 False 2019-05-14T16:29:00Z H.R. 2374, Stop STALLING Act https://www.cbo.gov/publication/55245 As ordered reported by the House Committee on the Judiciary on April 30, 2019 Health Administrative law and regulatory procedures Business ethics Civil actions and liability Competition and antitrust Drug safety, medical device, and laboratory regulation Federal Trade Commission (FTC) Licensing and registrations Public participation and lobbying Health 00 2019-04-29 Introduced in House 2021-09-12T15:47:21Z Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the Stop STALLING Act

This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.

The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.
]]> 07 2020-12-24 Reported to House 2021-09-12T15:50:14Z Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the Stop STALLING Act

This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.

The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.
]]> Stop STALLING Act Display Title Stop STALLING Act Official Title as Introduced To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes. Reported in House RH Short Title(s) as Introduced Stop STALLING Act Introduced in House IH Short Title(s) as Introduced Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act Introduced in House IH Short Title(s) as Reported to House Stop STALLING Act H House Reported in House RH Short Title(s) as Reported to House Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act H House Reported in House RH Reported in House 2020-12-24T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr2374rh/xml/BILLS-116hr2374rh.xml Introduced in House 2019-04-29T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr2374ih/xml/BILLS-116hr2374ih.xml 2020-12-24 Placed on the Union Calendar, Calendar No. 577. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.